Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» vadastuximab talirine
vadastuximab talirine
FDA padlocks any new human tests on Seattle Genetics’ cancer drug in the wake of more deaths
Endpoints
Thu, 06/22/17 - 09:38 am
FDA
Seattle Genetics
clinical trials
vadastuximab talirine
AML
acute myeloid leukemia
Seattle Genetics ends clinical trial of leukemia drug after ‘a higher rate of deaths’
Seattle Times, WA
Mon, 06/19/17 - 11:38 pm
Seattle Genetics
clinical trials
vadastuximab talirine
AML
acute myeloid leukemia
Seattle Genetics resumes two leukemia trials, ends one after FDA lifts hold
Bizjournals.com
Wed, 03/8/17 - 09:50 am
Seattle Genetics
clinical trials
FDA
vadastuximab talirine
Seattle Genetics to resume trials as FDA lifts clinical hold
Yahoo/Reuters
Mon, 03/6/17 - 09:52 am
Seattle Genetics
clinical trials
FDA
vadastuximab talirine
AML
acute myeloid leukemia
Seattle Genetics shares drop 13% on news of FDA holds on several early-stage clinical trials
Marketwatch
Tue, 12/27/16 - 01:47 pm
Seattle Genetics
FDA
vadastuximab talirine
acute myeloid leukemia
